The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
By 2030, How Much Growth In Market Size Is Expected For The Pharmaceutical Continuous Manufacturing Market?
The pharmaceutical continuous manufacturing market size has seen rapid growth in recent years. It is forecast to increase from $2.69 billion in 2025 to $2.97 billion in 2026, achieving a compound annual growth rate (CAGR) of 10.4%. The expansion observed historically can be attributed to factors like rising volumes of drug demand, the necessity for better production efficiency, considerable variability in batch manufacturing, heightened cost pressures on pharmaceutical companies, and early approvals for regulatory pilot projects.
The pharmaceutical continuous manufacturing market is projected to experience substantial expansion in the coming years. It is forecast to reach $4.58 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 11.4%. This anticipated growth is primarily attributable to the increasing adoption of pharmaceutical continuous manufacturing (PCM) by major pharmaceutical corporations, higher investments in intelligent factories, the imperative for accelerated scale-up and market introduction, an intensified focus on resilient supply chains, and innovations in continuous processing equipment. Significant developments expected during this forecast period include a transition from batch production to comprehensive end-to-end continuous manufacturing, a greater uptake of modular and adaptable production lines, an amplified emphasis on real-time quality assurance and control, the expansion of continuous manufacturing into API production, and growing regulatory endorsement for continuous manufacturing.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12123&type=smp
Which Major Factors Are Contributing To The Development Of The Pharmaceutical Continuous Manufacturing Market?
The expanding adoption of industrial automation is projected to propel the future growth of the pharmaceutical continuous manufacturing market. This automation involves employing control systems, such as computers and robots, to manage various industrial processes and machinery, thereby substituting or enhancing human involvement. Within pharmaceutical continuous manufacturing, industrial automation facilitates effective monitoring and real-time feedback control in CM processes, aiming to reduce human errors and guarantee uniform product quality. For instance, the World Robotics report, issued by the Germany-based International Federation of Robotics in September 2023, revealed 553,052 industrial robot installations globally in factories, indicating a 5% year-on-year increase in 2022. Consequently, the rising prevalence of industrial automation is a key factor fueling the development of the pharmaceutical continuous manufacturing market.
What Segment Categories Are Evaluated In The Pharmaceutical Continuous Manufacturing Market Study?
The pharmaceutical continuous manufacturing market covered in this report is segmented –
1) By Product: Integrated Continuous System, Control And Software, Semi-Continuous System
2) By Therapeutics Type: Large Molecule, Small Molecule
3) By Formulation: Solid Formation, Liquid And Semi-Solid Formation
4) By Application: Final Drug Product Manufacturing, Active Pharmaceutical Ingredient (API) Manufacturing
5) By End-Users: Pharmaceutical Companies, Contract Manufacturing Organization, Other End-Users
Subsegments:
1) By Integrated Continuous System: Continuous Mixer Systems, Continuous Granulation Systems, Continuous Tablet Press Systems, Continuous Coating Systems
2) By Control and Software: Process Analytical Technology (PAT) Tools, Manufacturing Execution Systems (MES), Control Software for Automation, Data Management and Visualization Software
3) By Semi-Continuous System: Batch-to-Continuous Transition Systems, Hybrid Systems, Semi-Continuous Granulation and Drying Systems
What Trends Are Affecting The Growth Of The Pharmaceutical Continuous Manufacturing Market?
Leading companies in the pharmaceutical continuous manufacturing market are concentrating on developing advanced equipment, such as continuous manufacturing lines, to achieve a competitive advantage. A Continuous Manufacturing (CM) line represents a specialized production system where raw materials are smoothly processed into final products without pauses or breaks. As an illustration, in January 2023, WuXi STA, a contract research, development, and manufacturing organization (CRDMO) based in China, introduced its Continuous Manufacturing (CM) line for oral solids in Wuxi City, China. This particular CM line meets global cGMP regulations and brings progress to oral drug development by featuring continuous direct compression equipment for tasks like dispensing, blending, lubrication, tablet compression, and coating. Significantly, Process Analytical Technology (PAT) is built-in to continuously observe blending uniformity, thereby assuring high product quality.
Who Are The Major Companies Operating In The Pharmaceutical Continuous Manufacturing Market?
Major companies operating in the pharmaceutical continuous manufacturing market are Pfizer Inc., Robert Bosch GmbH, Siemens AG, Novartis AG, Thermo Fisher Scientific Inc., GlaxoSmithKline Plc., Eli Lilly and Company, Corning Inc., Vertex Pharmaceuticals, Lonza Group Ltd., GEA Group AG, Catalent Inc., Mettler Toledo, Patheon, Cytiva, Samsung Biologics Co.Ltd., WuXi Biologics, Syntegon Technology GmbH, Coperion GmbH, Hosokawa Micron Group, FUJIFILM Diosynth Biotechnologies, Leistritz AG, Glatt GmbH, Freund-Vector Corp., SK biotek Co. Ltd., Gericke AG, GEBRÜDER LÖDIGE MASCHINENBAU GmbH, Munson Machinery Company Inc., L.B. Bohle Maschinen und Verfahren GmbH, KORSCH AG, Chemtrix BV
Access The Complete Pharmaceutical Continuous Manufacturing Market Report:
What Is The Largest Regional Market In The Pharmaceutical Continuous Manufacturing Market?
Western Europe was the largest region in the pharmaceutical continuous manufacturing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical continuous manufacturing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Pharmaceutical Continuous Manufacturing Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/sample.aspx?id=12123&type=smp
Browse Through More Reports Similar to the Global Pharmaceutical Continuous Manufacturing Market 2026, By The Business Research Company
Pharmaceutical Continuous Manufacturing Market Report 2026
Fill Finish Pharmaceutical Contract Manufacturing Market Report 2026
Pharmaceutical Contract Developments And Manufacturing Organization Cmo Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model